-
Product Insights
Asthma: Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Asthma - Global Clinical Trials Review, 2026" provides an overview of Asthma Clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Progressive Pulmonary Fibrosis: Opportunity Assessment, Epidemiology, Disease Management, and Forecast to 2035
Why Does the Progressive Pulmonary Fibrosis Market Matter for Your Business? The progressive pulmonary fibrosis (PPF) therapeutics market is entering a new phase of development, driven by growing diagnosis rates, expanding research activity, and the advancement of late-stage disease-modifying therapies. This report provides a comprehensive analysis of the PPF market across the seven major markets (7MM) — the US, France, Germany, Italy, Spain, the UK, and Japan — including treatment trends, pipeline products, competitive dynamics, unmet needs, and market forecasts...
-
Product Insights
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease): Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) - Global Clinical Trials Review, 2026" provides an overview of Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Bronchiectasis - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Bronchiectasis - Global Clinical Trials Review, 2025" provides an overview of Bronchiectasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Idiopathic Pulmonary Fibrosis (IPF) Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2034
This report covers the 7 major markets and provides an Excel-based forecast model for the Idiopathic Pulmonary Fibrosis (IPF) market through 2034. GlobalData estimated that drug sales for IPF in 2024 were approximately $2.7 billion across the 7MM, with the market size anticipated to grow to approximately $5.8 billion by 2034, at a compound annual growth rate (CAGR) of 7.7%. Major drivers of growth during the forecast period include the launches of several pipeline agents, most notably Jascayd (nerandomilast), Tyvaso...
-
Sector Analysis
Cell and Gene Therapies in Respiratory Disorders: Therapeutic Analysis, Treatment Options, Regulations, Sales Forecast and Future Market Assessment
The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date.
-
Sector Analysis
Idiopathic Pulmonary Fibrosis: Epidemiology Forecast to 2034
Idiopathic pulmonary fibrosis (IPF), a type of interstitial lung disease (ILD), is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs (National Heart Lung and Blood Institute, 2023). Environmental factors such as smoking, chronic aspiration, or respiratory infections, combined with advancing age, are the likely driving factors for the pathogenesis of IPF by causing respiratory alveolar epithelial injury (Sankari, Chapman and Ullah, 2024). These factors can cause permanent scarring in the lungs,...
-
Sector Analysis
Cystic Fibrosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2034
This report deliverables include a PowerPoint report and an Excel-based forecast model and covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Canada). The base year of the sales forecast model is 2024, and the forecast period is 2024-2034. This report also includes a number of recent enhancement to the forecast models, specifically the US LoA analysis tab and the interactive patient flow tab. The patient flow tab helps to summarize the number of patients treated...
-
Product Insights
Bronchitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Bronchitis - Global Clinical Trials Review, 2025" provides an overview of Bronchitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2025" provides an overview of Idiopathic Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Idiopathic Pulmonary Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.